Clopidogrel Tablets Recalled for Foreign Matter Contamination
Macleods Pharma USA is recalling Clopidogrel 75 mg tablets due to the presence of foreign matter in the product. The affected lot was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. The source text states only the presence of foreign matter without reporting any actual illnesses, injuries, or deaths. Foreign matter contamination in a pharmaceutical product is a safety concern that warrants recall, but without confirmed adverse health outcomes it does not meet the threshold for a higher severity rating.
Plain-English summary
Macleods Pharma USA Inc is recalling Clopidogrel (Clopidogrel Bisulfate) Tablets, USP, 75 mg, in 500-count bottles due to the presence of foreign matter in the product.
The recalled product is Lot # BCA82021A with expiration date 06/2023. This lot comprised approximately 444,000 tablets across 888 unit packs and was distributed nationwide. The product is manufactured by Macleods Pharmaceutical Ltd. in Baddi, Himachal Pradesh, India, and is distributed by Macleods Pharma USA, Inc., located in Plainsboro, NJ 08536. The relevant NDC number is 33342-060-15.
Clopidogrel is a prescription oral antiplatelet medication. Patients currently taking this medication should contact their healthcare provider if they have concerns or questions about the safety of their supply. Healthcare providers and pharmacies should quarantine and return affected product to the recalling firm.
The recalled product
- Product
- CLOPIDOGREL (CLOPIDOGREL)
- Brand
- CLOPIDOGREL
- Manufacturer
- Macleods Pharma Usa Inc
- Category
- Drug — Prescription Antiplatelet
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # BCA82021A
- Exp 06/2023
UPCs (3)
- 0333342060440
- 0333342060075
- 0333342060105
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Macleods Pharma Usa Inc
See all →- HighMacleods levothyroxine 150 microgram tablets recalled as a subpotent drug
FDA (Drugs) · 2026-04-01
- HighLosartan Potassium and Hydrochlorothiazide Tablets Recalled for Foreign Plastic Contamination
FDA (Drugs) · 2024-05-22
- ModerateLevofloxacin Tablets Recalled for Embossing and Packaging Insert Mismatch
FDA (Drugs) · 2023-01-25
- ModerateEszopiclone sleep medication recalled nationwide for shortfill packaging defect
FDA (Drugs) · 2022-07-13
- HighFDA Recalls Losartan-Hydrochlorothiazide Tablets for Manufacturing Quality Deviations
FDA (Drugs) · 2022-07-06
Same hazard · foreign matter
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateDivalproex Sodium Delayed-Release Tablets Recalled Due to Presence of Foreign Tablets
FDA (Drugs) · 2026-07-29
- ModeratePasteurized donor human milk bottles show dark spot contamination
FDA (Food) · 2026-06-17
- ModerateVitamin B-Complex and Vitamin C Dietary Supplement Recalled for Foreign Matter
FDA (Food) · 2026-05-27